v3.26.1
Condensed Consolidated Statements of Changes in Stockholders Equity (Unaudited) - USD ($)
$ in Thousands
Total
Numed
Renergen
Public Offering
Common Stock
Common Stock
Numed
Common Stock
Renergen
Common Stock
Public Offering
Treasury Stock
Treasury Stock
Numed
Treasury Stock
Renergen
Treasury Stock
Public Offering
Additional Paid-In Capital
Additional Paid-In Capital
Numed
Additional Paid-In Capital
Renergen
Additional Paid-In Capital
Public Offering
Accumulated Other Comprehensive (Loss) Income
Accumulated Other Comprehensive (Loss) Income
Numed
Accumulated Other Comprehensive (Loss) Income
Renergen
Accumulated Other Comprehensive (Loss) Income
Public Offering
Accumulated Deficit
Accumulated Deficit
Numed
Accumulated Deficit
Renergen
Accumulated Deficit
Public Offering
Noncontrolling Interest
Noncontrolling Interest
Numed
Noncontrolling Interest
Renergen
Noncontrolling Interest
Public Offering
Balance, shares at Dec. 31, 2024         72,068,059                                              
Balance, amount at Dec. 31, 2024 $ 51,167       $ 721       $ 0       $ 105,515       $ (2,164)       $ (56,173)       $ 3,268      
Stock-based compensation expense 1,890       0       0       1,890       0       0       0      
Distribution to noncontrolling interest of VIE (38)       0       0       0       0       0       (38)      
Foreign currency translation 1,171       0       0       0       1,171       0       0      
Net loss (8,462)       $ 0       0       0       0       (8,446)       (16)      
Balance, shares at Mar. 31, 2025         72,068,059                                              
Balance, amount at Mar. 31, 2025 45,728       $ 721       0       107,405       (993)       (64,619)       3,214      
Balance, shares at Dec. 31, 2024         72,068,059                                              
Balance, amount at Dec. 31, 2024 51,167       $ 721       0       105,515       (2,164)       (56,173)       3,268      
Distribution to noncontrolling interest of Renergen 0                                                      
Net loss - continuing operations (83,619)                                                      
Net loss (83,619)                                                      
Balance, shares at Jun. 30, 2025         83,905,417                                              
Balance, amount at Jun. 30, 2025 28,311       $ 839       0       164,045       30       (139,682)       3,079      
Balance, shares at Mar. 31, 2025         72,068,059                                              
Balance, amount at Mar. 31, 2025 45,728       $ 721       0       107,405       (993)       (64,619)       3,214      
Issuance of restricted common stock, shares         2,923,783     7,518,797                                        
Issuance of restricted common stock 0     $ 46,761 $ 29     $ 75 0     $ 0 (29)     $ 46,686 0     $ 0 0     $ 0 0     $ 0
Settlement of liabilities with consultants, shares         100,000                                              
Settlement of liabilities with consultants, amount 653       $ 1       0       652       0       0       0      
Issuance Of Common Stock From Exercise Of Warrants Amount 4,915       $ 13       0       4,902       0       0       0      
Issuance Of Common Stock From Exercise Of Warrants Shares         1,294,778                                              
Stock-based compensation expense 4,429       $ 0       0       4,429       0       0       0      
Distribution to noncontrolling interest of VIE (41)       0       0       0       0       0       (41)      
Foreign currency translation 1,023       0       0       0       1,023       0       0      
Net loss - continuing operations (75,157)                                                      
Net loss (75,157)       $ 0       0       0       0       (75,063)       (94)      
Balance, shares at Jun. 30, 2025         83,905,417                                              
Balance, amount at Jun. 30, 2025 28,311       $ 839       0       164,045       30       (139,682)       3,079      
Balance, shares at Dec. 31, 2025         111,677,771                                              
Balance, amount at Dec. 31, 2025 262,898       $ 1,117       $ 0       431,757       2,542       (231,265)       58,747      
Issuance of common stock to acquire Renergen, shares             14,270,000                                          
Issuance of common stock to acquire Renergen     $ 92,897       $ 142       $ 0       $ 92,755       $ 0       $ 0       $ 0  
Forfeiture of restricted common stock, shares         (44,324)       (44,324)                                      
Forfeiture of restricted common stock 0       $ 0       $ 0       0       0       0       0      
Stock-based compensation expense 4,412       0       0       4,412       0       0       0      
Deconsolidation of subsidiary (86,783)       0       0       0       (9)       0       (86,774)      
Fair value of noncontrolling interest at acquisition   $ 597 7,276     $ 0 0     $ 0 0     $ 0 0     $ 0 0     $ 0 0     $ 597 7,276  
Distribution to noncontrolling interest of Renergen     (380)       0       0       0       0       (380)       0  
Contributions from noncontrolling interest 26,960       0       0       0       0       0       26,960      
Distribution to noncontrolling interest of VIE (257)       0       0       0       0       0       (257)      
Foreign currency translation (6,259)       0       0       0       (6,688)       0       429      
Reclassification to earnings 0       0       0       0       1,496       (1,496)       0      
Net loss - continuing operations (26,706)       0       0       0       0       (26,463)       (243)      
Gain on deconsolidation 20,832       0       0       0       0       20,832       0      
Net income - discontinued operations 3,530       $ 0       $ 0       0       0       249       3,281      
Balance, shares at Mar. 31, 2026                 44,324                                      
Balance, shares at Mar. 31, 2026         125,903,447                                              
Balance, amount at Mar. 31, 2026 299,017       $ 1,259       $ 0       528,924       (2,659)       (238,523)       10,016      
Balance, shares at Dec. 31, 2025         111,677,771                                              
Balance, amount at Dec. 31, 2025 $ 262,898       $ 1,117       $ 0       431,757       2,542       (231,265)       58,747      
Issuance of common stock from exercise of options, shares 62,766                                                      
Distribution to noncontrolling interest of Renergen $ 1,109                                                      
Net loss - continuing operations (60,699)                                                      
Net loss (41,114)                                                      
Balance, shares at Jun. 30, 2026                 131,824                                      
Balance, shares at Jun. 30, 2026         130,148,698                                              
Balance, amount at Jun. 30, 2026 274,790       $ 1,301       $ 1       533,562       2,666       (272,837)       10,097      
Balance, shares at Mar. 31, 2026         125,903,447                                              
Balance, amount at Mar. 31, 2026 299,017       $ 1,259       0       528,924       (2,659)       (238,523)       10,016      
Issuance of common stock from exercise of options, shares         62,766                                              
Issuance of common stock from exercise of options 139       $ 0       0       139       0       0       0      
Issuance of restricted common stock, shares         4,273,555                                              
Issuance of restricted common stock 0       $ 43       $ 0       (43)       0       0       0      
Forfeiture of restricted common stock, shares         (91,070)       (87,500)                                      
Forfeiture of restricted common stock 0       $ (1)       $ (1)       0       0       0       0      
Stock-based compensation expense 4,542       0       0       4,542       0       0       0      
Distribution to noncontrolling interest of Renergen     $ (729)       $ 0       $ 0       $ 0       $ 0       $ (729)       $ 0  
Distribution to noncontrolling interest of VIE (215)       0       0       0       0       0       (215)      
Foreign currency translation 6,029       0       0       0       5,325       0       704      
Net loss - continuing operations (33,993)                                                      
Net loss (33,993)       $ 0       $ 0       0       0       (33,585)       (408)      
Balance, shares at Jun. 30, 2026                 131,824                                      
Balance, shares at Jun. 30, 2026         130,148,698                                              
Balance, amount at Jun. 30, 2026 $ 274,790       $ 1,301       $ 1       $ 533,562       $ 2,666       $ (272,837)       $ 10,097